Page 2 - Chip Baird News Today

By Dean Seal The chief executive of 2seventy Bio plans to step down as the company prepares to eliminate 176 roles, or about 40% of its workforce, in a...

Abecma generated $115 million U.S. commercial revenue in 2Q 2023, supporting lower end of U.S. revenue guidance of $470-570 million 2seventy bio provides update on PLAT-08 study in AML with... -Today at 07:04 am- MarketScreener

/PRNewswire/ -- Windham Mountain announced today major plans to further develop the ski resort, adding to its six-decade legacy as the premier Catskills...

/PRNewswire/ -- 360training (or "the Company"), a leading provider of online training and continuing education to regulated industries, today announced an...

Businesses everywhere are struggling to fill their staff as pandemic related federal unemployment benefits are set to end Labor Day.

Bluebird revealed the name of the oncology spinoff and the thinking behind the moniker. (Bluebird Bio) Bluebird bio has disclosed the name of its oncology spinoff: 2seventy bio. The spinoff is taking cancer therapies and some executives, including the CEO and chief scientific officer, from bluebird. Massachusetts-based bluebird first shared details of its plans to spin off its cancer assets into a new publicly traded company in January. Bluebird framed the separation as the way to bes...

North Castle Partners Announces Promotions News provided by Share this article Share this article GREENWICH, Conn., Jan. 7, 2021 /PRNewswire/ -- North Castle Partners, a leading private equity firm focused on consumer businesses that promotes Healthy, Active and Sustainable Living, is pleased to announce the following five promotions:  Alyse Skidmore and David Weston have been promoted to Partner, Roy Chin to Principal, and Jennifer Barsky and Alan Bui to Vice President. Alyse Skidmore, who ...